As an intestinal a-glucosidase, accumulating evidence indicates that gut microbiota dysbiosis is a core driver of cardiometabolic risk factors such as atherosclerosis [31], suggesting that MGAM may indirectly influence AMI through the "gut-heart axis". The gene discussed is MGAM; the disease is atherosclerosis.